News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
ROBIN SHERRINGTON
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/14/2023 |
4
| ROBIN SHERRINGTON (EVP, Strategy & Innovation) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Granted 75,000 options to buy
@ $34.18, valued at
$2.6M
|
|
| 09/02/2022 |
4
| ROBIN SHERRINGTON (EVP, Strategy & Innovation) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Paid exercise price by delivering 1,572 shares
@ $37.86, valued at
$59.5k
Sold 21,352 shares
@ $38.57, valued at
$823.5k
Paid exercise price by delivering 6,121 shares
@ $38.81, valued at
$237.6k
Sold 35,103 shares
@ $38.03, valued at
$1.3M
Sold 8,776 shares
@ $38.8, valued at
$340.5k
Exercised 17,488 options to buy
@ $2.67, valued at
$46.7k
Exercised 5,000 options to buy
@ $4.75, valued at
$23.8k
Exercised 50,000 options to buy
@ $4.75, valued at
$237.5k
|
|
| 03/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2020 |
4
| ROBIN SHERRINGTON (EVP, Strategy & Innovation) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Exercised 8,230 shares
@ $3.56, valued at
$29.3k
Paid exercise price by delivering 1,630 shares
@ $13.7, valued at
$22.3k
Exercised 8,230 options to buy
@ $0 |
|
| 03/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/18/2019 |
4
| ROBIN SHERRINGTON (EVP, Strategy & Innovation) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Granted 45,000 options to buy
@ $9.44, valued at
$424.8k
|
|
| 09/13/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2018 |
4
| ROBIN SHERRINGTON (EVP Bus. & Corp. Development) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Exercised 3,086 shares
@ $3.77, valued at
$11.6k
Paid exercise price by delivering 1,928 shares
@ $4.625, valued at
$8.9k
Exercised 3,086 options to buy
@ $0 |
|
| 03/13/2018 |
4
| ROBIN SHERRINGTON (EVP Bus. & Corp. Development) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Granted 55,000 options to buy
@ $4.75, valued at
$261.3k
|
|
| 10/24/2017 |
4
| ROBIN SHERRINGTON (SVP Bus. & Corp. Development) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Granted 11,000 options to buy
@ $3.1, valued at
$34.1k
|
|
| 05/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/11/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|